← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2011Last known activity
Jul 31, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 6 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (9)
- NCT06356025Lead sponsorPhase 4Jul 31, 2024
- NCT06356025OfficialPhase 4Jul 31, 2024
- NCT05569772CollaboratorPhase 3Mar 31, 2023
- NCT05097261CollaboratorPhase 4Sep 6, 2021
- NCT04750291Overall official - principal investigatorPhase 4Aug 9, 2021
- NCT04750291Reponsible party - principal investigatorPhase 4Aug 9, 2021
- NCT04750291Lead sponsorPhase 4Aug 9, 2021
- NCT03476109CollaboratorPhase 4Mar 30, 2018
- NCT01428973CollaboratorPhase 2Sep 1, 2011
Details
- Last known activity
- Jul 31, 2024